1
0
0
(1 - 25 von 25
)
Predicting the survival probability of gastric cancer patients...
www.proquest.com
Dirk Rades • Stefan Huttenlocher • Tobias Bartscht •. Steven E. Schild. Received: 26 June Accepted: 29 December Published ...
Frequency and Risk Factors of Sleep Disturbances in Patients With...
www.urotoday.com
Many patients with prostate cancer receive definitive or adjuvant radiotherapy. This study aimed to identify the frequency of sleep disturbances and...
A predictive tool particularly designed for elderly myeloma ...BMC Cancer
bmccancer.biomedcentral.com
von D Rades · · Zitiert von: 7 — Tobias Bartscht & … Steven E. Schild. Show authors. BMC Cancer volume ... Niklas Gebauer & Tobias Bartscht. Mayo Clinic, Scottsdale, AZ, USA.
Dasatinib blocks transcriptional and promigratory responses ...Molecular Cancer
molecular-cancer.biomedcentral.com
von T Bartscht · · Zitiert von: 34 — Tobias Bartscht, Benjamin Rosien, Harald Biersack, Hendrik Lehnert, Frank Gieseler & Hendrik Ungefroren. Department of Radiation Oncology ...
Metastatic spinal cord compression from pancreatic cancer. | PubFacts
www.pubfacts.com
PubFacts seeks to make the world's scientific research easy to locate, access, and collaborate on.
Tobias Bartscht
www.infona.pl
Tobias Bartscht. Details · Publications ... Stephan Hellmig, Tobias Bartscht, Wolfgang Fischbach, Stephan Johannes Ott, more · European Journal of Cancer ...
Anti-Cancer Agents in Medicinal Chemistry, Volume Number 7
benthamscience.com
Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with th...
A Scoring Tool to Estimate the Survival of Elderly Patients ...Anticancer Research
ar.iiarjournals.org
... TOBIAS BARTSCHT, STEVEN E. SCHILD and DIRK RADES. Anticancer Research March 2020, 40 (3) ; DOI: https://doi.org anticanres TRANG ...
Cited By (CrossRef) - Spandidos Publicationswww.spandidos-publications.com › html
www.spandidos-publications.com
Tobias Bartscht et al, 2015, Molecular Cancer CrossRef; Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in ...
Dr. Steven Schild, MD – Scottsdale, AZ | Radiation Oncology
www.doximity.com
Svenja Kopelke, Tobias Bartscht, Steven E. Schild, Soeren Tvilsted, Troels W. Kjaer, Dirk Rades> ;Anticancer Research Oct 1.
Cited By (CrossRef)Spandidos Publications
www.spandidos-publications.com
Tobias Bartscht et al, 2015, Mol Cancer CrossRef; TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK ...
Performance Status Is Associated With Survival in Elderly Patients...
ar.iiarjournals.org
... in Elderly Patients Irradiated for Cerebral Metastases from Prostate Cancer. TRANG NGUYEN, TOBIAS BARTSCHT, STEVEN E. SCHILD and DIRK RADES.
Evaluation of Pre-radiotherapy Sleep Disorders in Patients With ...regsj.dk
pure-portal.regsj.dk
Evaluation of Pre-radiotherapy Sleep Disorders in Patients With Rectal or Anal Cancer. Dirk Rades, Svenja Kopelke, Tobias Bartscht, Steven E Schild, Soeren ...
Risk Factors for Sleep Disturbances in Patients Scheduled for ...ar.iiarjournals.org › content › tab-figures-data
ar.iiarjournals.org
DIRK RADES, SVENJA KOPELKE, TAMER SOROR, TOBIAS BARTSCHT, SOEREN TVILSTED, TROELS W. KJAER and STEVEN E. SCHILD. Anticancer Research October 2021, ...
Predicting the survival probability of Springer Medicinespringermedicine.com
www.springermedicine.com
— Authors: Dirk Rades, Stefan Huttenlocher, Tobias Bartscht, Steven E. Schild. Published in: Gastric Cancer | Issue · Login to get access ...
The Src family kinase inhibitors PP2 and PP1 effectively block...
www.bionity.com
— Authors: Tobias Bartscht, Hendrik Lehnert, Frank Gieseler, Hendrik Ungefroren. Journal: Cancer Chemotherapy and Pharmacology.
Predicting the survival probability of gastric cancer Mayo ClinicElsevier
mayoclinic.elsevierpure.com
Dirk Rades, Stefan Huttenlocher, Tobias Bartscht, Steven E. Schild. Radiation Oncology. Research output: Contribution to journal › Article › peer-review
Sleep Disturbances in Lung Cancer Patients Assigned to ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von D Rades · · Zitiert von: 7 — ... Tobias Bartscht. Affiliations. 1 Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; . 2 Department of Radiation ...
Predicting the survival probability of gastric cancer patients...
mayoclinic.pure.elsevier.com
Dirk Rades ; Stefan Huttenlocher ; Tobias Bartscht ; Steven E. Schild · Radiation Oncology. To create a tool for estimating the survival of gastric cancer patients ...
V6630Sigma-Aldrich
www.sigmaaldrich.com
Tobias Bartscht et al. Molecular cancer, 14, ( ). We have previously shown in pancreatic ductal adenocarcinoma (PDAC) ...
Survival following palliative external-beam radiotherapy of locally...
mayoclinic.pure.elsevier.com
... external-beam radiotherapy of locally advanced and metastatic liver cancer. Dirk Rades, Louisa Bolm, Steven E. Schild, Tobias Bartscht.
The Src family kinase inhibitors PP2 and PP1 effectively block...
www.bionity.com
Autoren: Tobias Bartscht, Hendrik Lehnert, Frank Gieseler, Hendrik Ungefroren. Journal: Cancer Chemotherapy and Pharmacology. Jahrgang ...
Alle Infos zum Namen "Tobias Bartscht"
Verwandte Suchanfragen zu Tobias Bartscht
Axel Weber Svenja Kopelke Benjamin Rosien | Niklas Gebauer Stefan Schreiber Stephan Hellmig | Thorsten Sebens Hendrik Lehnert Robert Fölsch |
Personen Vorname "Tobias" (39044) Name "Bartscht" (58) |
sortiert nach Relevanz / Datum